JFL Life Sciences Limited (NSE:JFLLIFE)
9.85
+0.05 (0.51%)
At close: Sep 4, 2026
JFL Life Sciences Revenue
JFL Life Sciences had revenue of 111.02M INR in the quarter ending June 30, 2026, a decrease of -4.17%. This brings the company's revenue in the last twelve months to 1.31B, up 89.44% year-over-year. In the fiscal year ending March 31, 2026, JFL Life Sciences had annual revenue of 1.31B with 60.14% growth.
Revenue (ttm)
1.31B
Revenue Growth
+89.44%
P/S Ratio
0.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
325.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 493.40M | 60.14% |
| Mar 31, 2025 | 820.42M | 350.23M | 74.49% |
| Mar 31, 2024 | 470.19M | 28.09M | 6.35% |
| Mar 31, 2023 | 442.10M | 99.00M | 28.85% |
| Mar 31, 2022 | 343.10M | 15.40M | 4.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Rajnish Wellness | 1.68B |
| ANG Lifesciences India | 862.13M |
| Deccan Health Care | 818.34M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 492.78M |
| Gujarat Terce Laboratories | 456.22M |